SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: bugz who wrote (8659)5/28/1998 8:30:00 PM
From: DaiS  Read Replies (1) | Respond to of 23519
 
Bugz,

Had quick look on Abbot web site, missed the drug. What's it called?

DaiS



To: bugz who wrote (8659)5/28/1998 10:03:00 PM
From: VLAD  Respond to of 23519
 
What is all of this talk suddenly about "other" drugs?

Again we are comparing apples to oranges ie a systemic approach to a local approach. The orals will all have their own side effects and limitations on organic ED.

Read my lips worry warts MUSE IS HERE TO STAY.

It may never be as popular as orals but it will always have its niche in the treatment of ED.

The more research I have done on response to Viagra in moderate to severe organic ED the more I am bullish on Vivus and MUSE.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News